Agarwal Arjun

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return -59% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Agarwal Arjun's trades of Oruka Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-18 2026-05-18 PlS Planned sale
51,793 -7.3%
216.21
US$3,700,927
51,793 -7.3% 216.21 US$3,700,927
2026-05-18 2026-05-18 PlS Planned sale
23,429 +47.8%
365.97
US$1,461,461
23,429 +47.8% 365.97 US$1,461,461
2026-05-18 2026-05-18 PlS Planned sale
82,920 +3.8%
218.91
US$2,340,294
82,920 +3.8% 218.91 US$2,340,294
2026-05-18 2026-05-18 PlS Planned sale
4,190 -15.7%
58.34
US$244,465
4,190 -15.7% 58.34 US$244,465
2026-05-18 2026-05-18 PrS Proposed sale
22,206
61.93
US$1,375,218
22,206 61.93 US$1,375,218
2026-03-17 2026-03-16 S Sale
395 -2.1%
41.30
US$16,313
395 -2.1% 41.30 US$16,313